Cargando…
Outcomes and expanding indications for robotic retroperitoneal lymph node dissection for testicular cancer
Treatment of testicular cancer has made significant progress in the past decades in terms of reduction of treatment-associated morbidity and preventing over-treatment. At the forefront of this progression is utilization of the da Vinci robot to perform retroperitoneal lymph node dissections (RPLNDs)...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185654/ https://www.ncbi.nlm.nih.gov/pubmed/34159101 http://dx.doi.org/10.21037/tau.2020.03.14 |
_version_ | 1783704829062807552 |
---|---|
author | Yang, Hailiu Obiora, Daisy Tomaszewski, Jeffrey J. |
author_facet | Yang, Hailiu Obiora, Daisy Tomaszewski, Jeffrey J. |
author_sort | Yang, Hailiu |
collection | PubMed |
description | Treatment of testicular cancer has made significant progress in the past decades in terms of reduction of treatment-associated morbidity and preventing over-treatment. At the forefront of this progression is utilization of the da Vinci robot to perform retroperitoneal lymph node dissections (RPLNDs) via a minimally invasive approach. The robot offers multiple potential advantages such as smaller incisions, improved 3D visualization, more precise dissection, and faster convalescence, leading to its increased usage the past several years. In this chapter, we summarize the recent progress made in robotic surgery for testicular cancer and its potential in the future. Promising preliminary data has also renewed interest in defining the role of primary RPLND in patients with seminoma, potentially sparing patients of the harmful long-term radiation and cisplatin-based chemotherapy. SEMS and PRIMETEST trials are ongoing trials that will provide significant insight into this area and potentially expand the role of robotic RPLND. |
format | Online Article Text |
id | pubmed-8185654 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-81856542021-06-21 Outcomes and expanding indications for robotic retroperitoneal lymph node dissection for testicular cancer Yang, Hailiu Obiora, Daisy Tomaszewski, Jeffrey J. Transl Androl Urol Review Article on Controversies in Minimally Invasive Urologic Oncology Treatment of testicular cancer has made significant progress in the past decades in terms of reduction of treatment-associated morbidity and preventing over-treatment. At the forefront of this progression is utilization of the da Vinci robot to perform retroperitoneal lymph node dissections (RPLNDs) via a minimally invasive approach. The robot offers multiple potential advantages such as smaller incisions, improved 3D visualization, more precise dissection, and faster convalescence, leading to its increased usage the past several years. In this chapter, we summarize the recent progress made in robotic surgery for testicular cancer and its potential in the future. Promising preliminary data has also renewed interest in defining the role of primary RPLND in patients with seminoma, potentially sparing patients of the harmful long-term radiation and cisplatin-based chemotherapy. SEMS and PRIMETEST trials are ongoing trials that will provide significant insight into this area and potentially expand the role of robotic RPLND. AME Publishing Company 2021-05 /pmc/articles/PMC8185654/ /pubmed/34159101 http://dx.doi.org/10.21037/tau.2020.03.14 Text en 2021 Translational Andrology and Urology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Review Article on Controversies in Minimally Invasive Urologic Oncology Yang, Hailiu Obiora, Daisy Tomaszewski, Jeffrey J. Outcomes and expanding indications for robotic retroperitoneal lymph node dissection for testicular cancer |
title | Outcomes and expanding indications for robotic retroperitoneal lymph node dissection for testicular cancer |
title_full | Outcomes and expanding indications for robotic retroperitoneal lymph node dissection for testicular cancer |
title_fullStr | Outcomes and expanding indications for robotic retroperitoneal lymph node dissection for testicular cancer |
title_full_unstemmed | Outcomes and expanding indications for robotic retroperitoneal lymph node dissection for testicular cancer |
title_short | Outcomes and expanding indications for robotic retroperitoneal lymph node dissection for testicular cancer |
title_sort | outcomes and expanding indications for robotic retroperitoneal lymph node dissection for testicular cancer |
topic | Review Article on Controversies in Minimally Invasive Urologic Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185654/ https://www.ncbi.nlm.nih.gov/pubmed/34159101 http://dx.doi.org/10.21037/tau.2020.03.14 |
work_keys_str_mv | AT yanghailiu outcomesandexpandingindicationsforroboticretroperitoneallymphnodedissectionfortesticularcancer AT obioradaisy outcomesandexpandingindicationsforroboticretroperitoneallymphnodedissectionfortesticularcancer AT tomaszewskijeffreyj outcomesandexpandingindicationsforroboticretroperitoneallymphnodedissectionfortesticularcancer |